Cargando…

Gut microbial characteristical comparison reveals potential anti-aging function of Dubosiella newyorkensis in mice

INTRODUCTION: Previous study has indicated Dubosiella newyorkensis may act as a potential probiotic in age-related diseases. However, its detailed role in aging has not yet been promulgated. This study aimed to explore the potential anti-aging role of Dubosiella newyorkensis by comparing the anti-ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tian-hao, Wang, Juan, Zhang, Chen-yang, Zhao, Lin, Sheng, Ying-yue, Tao, Guo-shui, Xue, Yu-zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928160/ https://www.ncbi.nlm.nih.gov/pubmed/36798665 http://dx.doi.org/10.3389/fendo.2023.1133167

Ejemplares similares

Whole-Genome Sequence of Listeria newyorkensis, Isolated from River Water in Japan
por: Ohshima, Chihiro, et al.
Publicado: (2019)

Gut microbiota profiling revealed the regulating effects of salidroside on iron metabolism in diabetic mice
por: Shi, Jing, et al.
Publicado: (2022)

Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice
por: Toft, Pernille Baumann, et al.
Publicado: (2023)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Gut microbial change after administration of Lacticaseibacillus paracasei AO356 is associated with anti-obesity in a mouse model
por: Song, Eun-Ji, et al.
Publicado: (2023)

Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
por: Fang, Qing, et al.
Publicado: (2021)

Integrated Metagenomics and Metabolomics to Reveal the Effects of Policosanol on Modulating the Gut Microbiota and Lipid Metabolism in Hyperlipidemic C57BL/6 Mice
por: Zhai, Zhenya, et al.
Publicado: (2021)

A Microbial Community Ecology Perspective on the Gut-Microbiome-Brain Axis
por: van der Goot, Els, et al.
Publicado: (2020)

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
por: Wang, Dongmei, et al.
Publicado: (2022)

Benefits of Huang Lian mediated by gut microbiota on HFD/STZ-induced type 2 diabetes mellitus in mice
por: Li, Dan, et al.
Publicado: (2023)

Leveraging mice with diverse microbial exposures for advances in osteoimmunology
por: Little-Letsinger, Sarah E., et al.
Publicado: (2023)

Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole
por: Li, Yushan, et al.
Publicado: (2023)

Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
por: Xu, Tian, et al.
Publicado: (2022)

Gut microbial dysbiosis in patients with Cushing’s disease in long-term remission. Relationship with cardiometabolic risk
por: Valassi, Elena, et al.
Publicado: (2023)

Case report: Clinical characteristics and treatment of secondary osteoporosis induced by X-linked congenital adrenal dysplasia
por: Tao, Xiaohui, et al.
Publicado: (2022)

The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus
por: Parekh, Parth J., et al.
Publicado: (2016)

Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
por: Zhou, Liyuan, et al.
Publicado: (2019)

Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
por: Tsai, Chih-Yiu, et al.
Publicado: (2022)

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway
por: Yue, Si-Ran, et al.
Publicado: (2022)

Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism
por: Qi, Shan Shan, et al.
Publicado: (2021)

Molecular anatomy of the gut-brain axis revealed with transgenic technologies: implications in metabolic research
por: Udit, Swalpa, et al.
Publicado: (2013)

Eating for 3.8 × 10(13): Examining the Impact of Diet and Nutrition on the Microbiota-Gut-Brain Axis Through the Lens of Microbial Endocrinology
por: Lyte, Joshua M.
Publicado: (2019)

Metagenomic analysis of gut microbial communities from a Central Asian population
por: Kushugulova, Almagul, et al.
Publicado: (2018)

Perturbation on gut microbiota impedes the onset of obesity in high fat diet-induced mice
por: Yu, Zhongjia, et al.
Publicado: (2022)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis
por: Xu, Yunxi, et al.
Publicado: (2022)

Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature
por: Li, Lin, et al.
Publicado: (2022)

Gut microbiota is associated with differential metabolic characteristics: A study on a defined cohort of Africans and Chinese
por: Nizigiyimana, Paul, et al.
Publicado: (2022)

Ovariectomy Impaired Hepatic Glucose and Lipid Homeostasis and Altered the Gut Microbiota in Mice With Different Diets
por: Lei, Zili, et al.
Publicado: (2021)

Association of Antibiotic Alterations in Gut Microbiota With Decreased Osseointegration of an Intramedullary Nail in Mice With and Without Osteomyelitis
por: Zhao, Xingqi, et al.
Publicado: (2021)

Gut microbial DNA and immune checkpoint gene Vsig4/CRIg are key antagonistic players in healthy aging and age-associated development of hypertension and diabetes
por: Liu, Matthew A., et al.
Publicado: (2022)

Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease
por: Masse, Karly E., et al.
Publicado: (2023)

Cross-species comparisons reveal resistance of human skeletal stem cells to inhibition by non-steroidal anti-inflammatory drugs
por: Goodnough, L. Henry, et al.
Publicado: (2022)

Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis
por: Huang, Ya-lan, et al.
Publicado: (2023)

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies
por: Cao, Thao T. B., et al.
Publicado: (2020)

Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice
por: Wang, Xin-shang, et al.
Publicado: (2022)

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022)

Circadian Rhythm Disruption Influenced Hepatic Lipid Metabolism, Gut Microbiota and Promoted Cholesterol Gallstone Formation in Mice
por: He, Chuanqi, et al.
Publicado: (2021)

Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
por: Covasa, Mihai, et al.
Publicado: (2019)

The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
por: Mallet, Christophe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g99or7eiuafs4ndpkkd3osn752